Anti-Inflammatory and Cytokine Regulation BPC-157 downregulates pro-inflammatory mediators including: Tumor Necrosis Factor-Alpha (TNF-) Interleukin-1 Beta (IL-1) Interleukin-6 (IL-6) Leukotrienes key drivers of pain and inflammation in arthritis and tendinopathy Growth Hormone Receptor Upregulation Emerging research suggests BPC-157 increases growth hormone receptor density in injured tissues, amplifying the natural repair signals that decline with age or chronic inflammation
Wockhardt offers global exports, hospital supplies, and innovative research
BULK PRICING (per product)applied automatically at cart no code needed 1019 vials: 10% off 2039: 20% 4069: 30% 70+: 40% Description Additional information FAQ The TB-500/BPC-157 blend combines two complementary research peptides: TB-500: A synthetic 43amino-acid analog of Thymosin -4, widely used to probe actin dynamics, cytoskeletal remodeling, and intracellular trafficking
It is studied for its potential to support tissue regeneration, angiogenesis, and cellular signaling in tendon, ligament, muscle, and gut models